Gateway Capital

Gateway Capital is a biotechnology project management company located in Perth, Western Australia. The company was formally incorporated to further progress and expand a business that has been operating since early 2021. Gateway's board of directors brings together a management team that provides experienced and dedicated commercial and scientific... expertise necessary to procure funding for its selected biotechnology projects. Gateway's Chairman, Mr Dalton Gooding, is a chartered accountant and a former long standing partner at Ernst & Young. He is supported by the Board of Directors consisting of Mr Harry Karelis, Mr Charles Morgan and Mr Gabriel Chiappini. Mr Karelis has 13 years experience in the funds management and biotechnology industries, and Mr Morgan more than 20 years experience in equity capital markets, early stage research and exploration and companies funded through the ASX. Mr Chiappini has over 10 years experience on Chief Financial Officer and Company Secretary roles in local and international environments.Read More